Korro Bio (KRRO) Competitors $37.00 +0.02 (+0.05%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends KRRO vs. SDGR, XNCR, ARDX, NRIX, KNSA, RCUS, OCUL, MRVI, ARVN, and PRAXShould you be buying Korro Bio stock or one of its competitors? The main competitors of Korro Bio include Schrödinger (SDGR), Xencor (XNCR), Ardelyx (ARDX), Nurix Therapeutics (NRIX), Kiniksa Pharmaceuticals (KNSA), Arcus Biosciences (RCUS), Ocular Therapeutix (OCUL), Maravai LifeSciences (MRVI), Arvinas (ARVN), and Praxis Precision Medicines (PRAX). These companies are all part of the "pharmaceutical products" industry. Korro Bio vs. Schrödinger Xencor Ardelyx Nurix Therapeutics Kiniksa Pharmaceuticals Arcus Biosciences Ocular Therapeutix Maravai LifeSciences Arvinas Praxis Precision Medicines Korro Bio (NASDAQ:KRRO) and Schrödinger (NASDAQ:SDGR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, community ranking, earnings and risk. Which has more volatility and risk, KRRO or SDGR? Korro Bio has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500. Comparatively, Schrödinger has a beta of 1.59, suggesting that its stock price is 59% more volatile than the S&P 500. Which has higher valuation and earnings, KRRO or SDGR? Schrödinger has higher revenue and earnings than Korro Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKorro BioN/AN/A-$81.17MN/AN/ASchrödinger$193.35M7.16$40.72M-$2.34-8.12 Does the media refer more to KRRO or SDGR? In the previous week, Korro Bio and Korro Bio both had 5 articles in the media. Schrödinger's average media sentiment score of 0.75 beat Korro Bio's score of 0.30 indicating that Schrödinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Korro Bio 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Schrödinger 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer KRRO or SDGR? Schrödinger received 29 more outperform votes than Korro Bio when rated by MarketBeat users. However, 100.00% of users gave Korro Bio an outperform vote while only 56.99% of users gave Schrödinger an outperform vote. CompanyUnderperformOutperformKorro BioOutperform Votes24100.00% Underperform VotesNo VotesSchrödingerOutperform Votes5356.99% Underperform Votes4043.01% Do insiders & institutionals have more ownership in KRRO or SDGR? 13.2% of Korro Bio shares are owned by institutional investors. Comparatively, 79.1% of Schrödinger shares are owned by institutional investors. 5.4% of Korro Bio shares are owned by insiders. Comparatively, 8.6% of Schrödinger shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is KRRO or SDGR more profitable? Korro Bio has a net margin of 0.00% compared to Schrödinger's net margin of -91.84%. Schrödinger's return on equity of -35.77% beat Korro Bio's return on equity.Company Net Margins Return on Equity Return on Assets Korro BioN/A -50.25% -38.48% Schrödinger -91.84%-35.77%-24.51% Do analysts rate KRRO or SDGR? Korro Bio currently has a consensus target price of $144.00, indicating a potential upside of 289.19%. Schrödinger has a consensus target price of $32.90, indicating a potential upside of 73.16%. Given Korro Bio's stronger consensus rating and higher possible upside, analysts plainly believe Korro Bio is more favorable than Schrödinger.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Korro Bio 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14Schrödinger 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.82 SummarySchrödinger beats Korro Bio on 9 of the 14 factors compared between the two stocks. Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRRO vs. The Competition Export to ExcelMetricKorro BioPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$346.69M$6.58B$5.36B$9.09BDividend YieldN/A2.95%5.13%4.03%P/E RatioN/A9.8389.4717.33Price / SalesN/A306.601,255.73134.95Price / CashN/A61.4443.7535.97Price / Book1.756.055.324.80Net Income-$81.17M$154.62M$122.60M$224.91M7 Day Performance4.93%-1.68%0.69%1.77%1 Month Performance-25.64%-2.35%1.55%2.22%1 Year Performance-15.20%1.02%27.25%20.67% Korro Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRROKorro Bio2.3422 of 5 stars$37.00+0.1%$144.00+289.2%-20.8%$346.69MN/A0.0070Short Interest ↑News CoverageSDGRSchrödinger1.8738 of 5 stars$19.47+0.9%$32.90+69.0%-31.8%$1.42B$193.35M-8.32790XNCRXencor4.2138 of 5 stars$20.26-1.7%$36.56+80.4%-1.8%$1.42B$85.16M-6.33280Positive NewsARDXArdelyx3.7438 of 5 stars$5.88+16.0%$9.25+57.3%-41.2%$1.39B$251.85M-19.6090Analyst ForecastHigh Trading VolumeNRIXNurix Therapeutics2.3167 of 5 stars$19.01+4.2%$30.35+59.7%+123.5%$1.35B$56.42M-6.53300KNSAKiniksa Pharmaceuticals2.8902 of 5 stars$18.17-8.8%$36.60+101.4%-0.1%$1.31B$384.10M-129.78220Insider TradeAnalyst RevisionNews CoverageGap DownRCUSArcus Biosciences1.8814 of 5 stars$13.98-1.5%$34.00+143.2%-16.1%$1.28B$263M-4.44500OCULOcular Therapeutix3.6635 of 5 stars$8.12-1.1%$16.71+105.8%+91.7%$1.28B$61.44M-6.15230News CoverageGap DownMRVIMaravai LifeSciences4.6362 of 5 stars$4.94+1.9%$10.28+108.1%-28.9%$1.25B$276.92M-3.01610ARVNArvinas2.5475 of 5 stars$18.01-3.3%$63.50+252.6%-53.9%$1.24B$161.10M-3.86420PRAXPraxis Precision Medicines2.0341 of 5 stars$64.02+1.4%$146.33+128.6%+70.7%$1.19B$1.61M-6.22110Short Interest ↑ Related Companies and Tools Related Companies Schrödinger Alternatives Xencor Alternatives Ardelyx Alternatives Nurix Therapeutics Alternatives Kiniksa Pharmaceuticals Alternatives Arcus Biosciences Alternatives Ocular Therapeutix Alternatives Maravai LifeSciences Alternatives Arvinas Alternatives Praxis Precision Medicines Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KRRO) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRRO Stock Alerts